Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.

scientific article published on January 2015

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/JVH.12350
P698PubMed publication ID25560839
P5875ResearchGate publication ID270645839

P50authorHomie RazaviQ37391777
Vladimir P. ChulanovQ56846666
Ezequiel RidruejoQ56846682
Robert FlisiakQ56980311
Inka AhoQ57304703
Waldemar HalotaQ63673102
Pagbajabyn NymadawaQ79298636
George PapatheodoridisQ42284105
Carole Seguin-DevauxQ42459569
Sarah BlachQ42986595
Joël MossongQ47816839
Catherine Wendy SpearmanQ56245939
Chris EstesQ56678759
Anil C AnandQ56808420
P2093author name stringP Hoffmann
S Acharya
C Henderson
M Prins
S R Shah
A Rakhmanova
Y Lurie
P Puri
R J de Knegt
A Hatzakis
C Bergin
D Struck
T Staub
V Arendt
H W Reesink
S Norris
V Sypsa
F R Zuure
O Baatarkhuu
A C Gadano
M O Silva
K Barclay
F Bessone
G Choudhuri
D Kershenobich
Z Ben-Ari
E Zuckerman
I Schréter
P Kristian
P Arkkila
A Mahomed
M Leshno
S Sokolov
E Gane
J Hornell
R Safadi
V Saraswat
P Jarčuška
D Houlihan
K Tomasiewicz
I Veldhuijzen
K Souliotis
S Radke
M I Andersson
A J van der Meer
E A Croes
E Gower
A Shevaldin
C R Brunton
C Stedman
D Davaadorj
D van Santen
E A Strebkova
E Nurmukhametova
F G Villamil
I Shestakova
J F Sanchez Avila
J Oyunbileg
J R Daruich
K Kostrzewska
K Razavi-Shearer
L Cisneros
L Undram
M de Vree
M Oltman
M Sonderup
N Blokhina
N Mamonova
N Mendez-Sanchez
N Pimenov
N Prabdial-Sing
N R Dashdorj
O Dalgard
O Sagalova
O Shibolet
R Sanduijav
S Hrusovsky
S Willemse
Ts Oyunsuren
Y A Dahgwahdorj
P2860cites workGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Q21534928
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalenceQ29616009
Epidemiology of viral hepatitis and hepatocellular carcinomaQ29617918
Evolving epidemiology of hepatitis C virusQ29619973
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002Q29619974
A systematic review of hepatitis C virus epidemiology in Asia, Australia and EgyptQ30403548
Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infectionQ35824825
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studiesQ36346436
The changing epidemiology of hepatitis C virus infection in EuropeQ37006042
Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from ArgentinaQ37221506
Trends and projections of hepatitis C virus epidemiology in Latin America.Q37886279
A systematic review of hepatitis C virus epidemiology in Europe, Canada and IsraelQ37886280
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmQ39213684
Seroprevalence and risk factors of hepatitis B and hepatitis C virus infections in uttarakhand, IndiaQ41258167
Estimating the treatment cascade of chronic hepatitis B and C in Greece using a telephone survey.Q41744442
Strategies to manage hepatitis C virus (HCV) disease burden.Q42226125
Hepatitis C virus seroprevalence in the NetherlandsQ42978867
Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide studyQ42980207
Hepatitis C virus seropositivity in a South African Cohort of HIV co-infected, ARV naïve patients is associated with renal insufficiency and increased mortalityQ42980230
Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.Q42981236
Predicted effects of treatment for HCV infection vary among European countriesQ42982945
Prevalence of hepatitis C virus in a selected geographical area of northern India: a population based surveyQ42985162
Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates.Q42997217
HCV infection in PolandQ43029694
Prevalence and risk factors of HCV infection in PolandQ43041364
Hepatitis C virus infection in the general population: a community-based study in West Bengal, IndiaQ43049060
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).Q43993163
Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrumQ44562896
Hepatitis C virus prevalence in The Netherlands: migrants account for most infectionsQ45354905
Hepatitis C virus infection during pregnancy in North IndiaQ45531117
Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policyQ46146376
[Liver transplantation in Norway through 25 years].Q51139887
P921main subjectHepatitis C virusQ708693
P304page(s)6-25
P577publication date2015-01-01
P1433published inJournal of Viral HepatitisQ15749962
P1476titleHistorical epidemiology of hepatitis C virus (HCV) in select countries - volume 2
P478volume22 Suppl 1

Reverse relations

cites work (P2860)
Q33918841A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound
Q40528954A simple real-time polymerase chain reaction assay using SYBR Green for hepatitis C virus genotyping.
Q92888058Accuracy of budget impact estimations and impact on patient access: a hepatitis C case study
Q52597014Approaches for simplified HCV diagnostic algorithms.
Q31148392Attempt to calculate the prevalence and features of chronic hepatitis C infection in Tuscany using administrative data
Q38637199Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents
Q41925862Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?
Q38613271Direct-acting antiviral agents for HCV infection affecting people who inject drugs
Q64068380Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals
Q40092669Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
Q28074447Epidemiology of hepatitis C in Greece
Q38946139Epidemiology of hepatitis C virus infection in a large Israeli health maintenance organization
Q41562313Estimates on HCV disease burden worldwide - filling the gaps
Q40932598Estimating HCV disease burden - volume 3 (editorial).
Q47589992Estimating HCV disease burden-volume 4 (editorial).
Q40228317Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study
Q38772047Genotype 3 Infection: The Last Stand of Hepatitis C Virus
Q30240220Global epidemiology and burden of HCV infection and HCV-related disease
Q38839762Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Q57166986Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework
Q47594606Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis
Q57030951Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir
Q30235491Hepatitis C virus infection
Q36924982Hepatitis C virus infection in Argentina: Burden of chronic disease.
Q36269670Hepatitis C virus infection: Are there still specific problems with genotype 3?
Q37620782Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and Africa
Q45325255Historical epidemiology of hepatitis C virus in select countries—volume 4
Q37040556Incident Hepatitis C Virus Genotype Distribution and Multiple Infection in Australian Prisons
Q92750665Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
Q38842781Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.
Q40189279Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study
Q47572592Ledipasvir-Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection
Q38931620Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.
Q37428608Pharmacokinetics of the New Hepatitis C Virus NS3 Protease Inhibitor Narlaprevir following Single-Dose Use with or without Ritonavir in Patients with Liver Cirrhosis
Q36067623Prevalence and knowledge of hepatitis C in a middle-aged population, Dunedin, New Zealand
Q97526372Prevalence of HBV and HCV infections, Bhutan, 2017: Progress and next steps
Q29353552Prevalence, determinants and genetic diversity of hepatitis C virus in the multi-ethnic population living in Suriname
Q92982844Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India
Q38661825Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Q41922681Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe
Q55191989Role of Direct Antiviral Agents in Treatment of Chronic Hepatitis C Infection in Renal Transplant Recipients.
Q37102817Specific Age and Gender Prevalence of Hepatitis C Virus Infection in Iran
Q91923463Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis
Q38982103Tackling the Hepatitis C Disease Burden in Punjab, India
Q37171340Viral hepatitis: Indian scenario

Search more.